Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT01521208
Other study ID # SEM-HVH-001
Secondary ID
Status Recruiting
Phase Phase 3
First received December 25, 2011
Last updated February 3, 2012
Start date January 2012
Est. completion date April 2014

Study information

Verified date February 2012
Source Sistema d’Emergències Mèdiques
Contact Francesc Carmona Jiménez, Doctor
Phone +34607847717
Email franciscojosecarmona@gencat.cat
Is FDA regulated No
Health authority Spain: Departament de Salut de la Generalitat de Catalunya
Study type Interventional

Clinical Trial Summary

The goal of this study is to show the superiority in survival at hospital admittance and in neurological outcome on hospital discharge of continuous mechanical chest compression using LUCAS device versus manual chest compressions in patients who suffered an out-of-hospital cardiac arrest.


Description:

The primary goals of the trial are:

- To show a survival increase at hospital admittance after out-of-hospital cardiac arrest of patients treated by continuous chest compressions LUCAS device compared with patients treated by manual chest compressions.

- To evaluate neurological outcome on hospital discharge, in two centres (Vall d'Hebron Hospital and Josep Trueta Hospital).


Recruitment information / eligibility

Status Recruiting
Enrollment 400
Est. completion date April 2014
Est. primary completion date February 2014
Accepts healthy volunteers No
Gender Both
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria:

- Age: between 18 and 80 years ,

- Suffering from NON traumatic or an unexpected SCA,

- SCA witnessed (seen, heard or monitored),

- Attended by an advanced support ambulance (served by doctor or nurse) in Barcelona city, or in the Girona or Lleida area

- Time between alarm-call to SEM 061 and reaching patient is less than 12 minutes.

Exclusion Criteria:

- Biological signs of death

- Age under 18 or over 80 years

- Trauma caused cardio respiratory arrest (CRA), including hanging

- Secondary CRA or intoxication

- Return of spontaneous circulation previous to arrival of SEM's medical team

- Known pregnancy

- Inadequate size for LUCAS device

- Anything in the study that can delay treatment

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Intervention

Device:
LUCAS (Lund University Cardiac Assist Sysrem)
LUCAS device will be placed on patients suffering a cardiac arrest and continuous chest compressions will be performed, even while defibrillation is being applied
Other:
Manual chest compressions
Manual CPR according to 2010 ERC guidelines will be performed

Locations

Country Name City State
Spain Hospital Vall d'Hebron Barcelona
Spain Sistema d'Emergències Mèdiques Hospitalet de Llobregat Barcelona

Sponsors (2)

Lead Sponsor Collaborator
Sistema d’Emergències Mèdiques Hospital Vall d'Hebron

Country where clinical trial is conducted

Spain, 

Outcome

Type Measure Description Time frame Safety issue
Primary Survival at hospital admittance The primary goal is to evaluate survival at hospital admittance of patients, after out-of hospital cardiac arrest treated by LUCAS device chest compressions, compared with those patients treated by manual chest compressions 2 hours No
Primary Survival on discharge from hospital (or 30 days if not applicable) in acceptable neurological state (CPC scale 1 or 2) Evaluate the neurological outcome on hospital discharge, in two centres (Vall d'Hebron Hospital in Barcelona and Josep Trueta Hospital in Girona) 1 or 2 in Cerebral Performance Category 30 days No
Secondary Restoration of spontaneous circulation To compare the return of spontaneous circulation (ROSC) between both groups 2 hours No
Secondary EndTidal CO2 values To compare EndTidal CO2 values of patients during cardiopulmonary resuscitation (CPR)between boths study arms Every four minutes during resuscitation maneuvers No
Secondary SOFA scale values To compare the first three days, on hospital discharge SOFA scale value and the worse value obtained (date and hour) in patients who survived out-of-hospital SCA and weere brought to either Vall d'Hebron Hospital or Josep Trueta Hospital. During the first three days and on hospital discharge No
Secondary Days before discharge from Intensive Care Unit (ICU) / Coronary Care Unit (CCU) To compare days before discharge from Intensive Care Unit (ICU) / Coronary Care Unit (CCU) in patients who survived out-of-hospital SCA and were brought to either Vall d'Hebron Hospital or Josep Trueta Hospital 30 days No
Secondary Metabolic (pH, lactate) and inflamatory (leukocytes, C reactive protein) parameters To establish the differences in metabolic (pH, lactate) and inflamatory (leukocytes, C reactive protein) parameters in patients who survived out-of-hospital SCA and were brought to either Vall d'Hebron Hospital or Josep Trueta Hospital During the first 24h, at >48h and at 5-7days No
Secondary Epidemiology of Out-of-Hospital Cardiac Arrest To describe the epidemiology of out-of-hospital SCA in the cities of Barcelona, Girona and Lleida 3 months No
Secondary To obtain a blood sample for genetic and biological studies Blood samples from SCA survivors will be kept to perform biological studies. 7 days No
Secondary Left ventricular function To compare left ventricular function in patients who survived at out-of-hospital sudden cardiac arrest and were brought to either Vall d'Hebron Hospital or Josep Trueta Hospital During the first 24h and during the 24h previous on hospital discharge or at two months No
See also
  Status Clinical Trial Phase
Completed NCT00226681 - Nurses Helping Sudden Cardiac Arrest Survivors Recover After Getting An Implantable Cardioverter Defibrillator (ICD) Phase 1
Recruiting NCT05799833 - Low QRS Voltages in Young Healthy Individuals and Athletes
Completed NCT05636332 - The Intrepid Clinical Engineering Study N/A
Recruiting NCT04250857 - HeartStart FRx Defibrillator Event Registry
Recruiting NCT02816047 - Austrian Wearable Cardioverter Defibrillator Registry
Completed NCT00918125 - Educational Videos to Improve Patient Decision Making and Race Disparities in Implantable Cardioverter Defibrillator Use N/A
Recruiting NCT05135403 - ASSURE WCD Clinical Evaluation - Post Approval Study (ACE-PAS)
Completed NCT03715790 - Improve SCA Bridge Study
Recruiting NCT03826524 - Epinephrine Dose: Optimal Versus Standard Evaluation Trial Phase 4
Recruiting NCT05855135 - Assessment of Combined CCM and ICD Device in HFrEF N/A
Completed NCT03065647 - ECPR for Refractory Out-Of-Hospital Cardiac Arrest N/A
Completed NCT02099721 - Improve Sudden Cardiac Arrest Study N/A
Recruiting NCT01822145 - A Feasibility Study on Prediction of an ICD Shock by ICD-derived Data N/A
Completed NCT01326624 - Study of the Wearable Defibrillator in Heart-Failure Patients N/A
Completed NCT03016754 - Heart Failure Optimization Study
Terminated NCT02481206 - Wearable Cardioverter Defibrillator in Hemodialysis Patients (WED-HED) Study N/A
Not yet recruiting NCT06447805 - Early Double Sequential Defibrillation in Out-of-hospital Cardiac Arrest N/A
Enrolling by invitation NCT04548804 - Better Mechanistic Understanding of and Risk Stratification for Ventricular Tachyarrhythmias Through ECGI N/A
Completed NCT05490459 - Jewel Electrophysiology (EP) Lab Study N/A
Completed NCT05201495 - The Jewel IDE Study N/A